$IRIX News

Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

IRIDEX Corporation Q1 2026 Earnings Call Summary

Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens

Iridex Reports First Quarter 2026 Financial Results

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Iridex Q1 2026 Earnings Call: Complete Transcript

Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est

Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

Iridex shares are trading higher after the company announced a new partnership with EyeProGPO to expand member access to retina laser technology.

Iridex shares are trading higher after the company announced a new partnership with EyeProGPO to expand member access to retina laser technology.

Iridex Announces New Partnership With EyeProGPO To Expand Access To Retinal Laser Technology

Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth

IRIDEX shares are trading lower after the company reported mixed Q4 financial results and issued FY26 sales guidance below estimates.

IRIDEX Corporation Q4 2025 Earnings Call Summary

IRIDEX (IRIX) Q4 2025 Earnings Call Transcript